FDA Investigator Garry H Stewart
Garry H Stewart has conducted inspections on 150 sites in 1 countries as of 29 Nov 2005. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
150
Last Inspection Date:
29 Nov 2005
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Garry H Stewart:
Aaron L Morris,
Abby E Pelletier,
Alan R Condon,
Aldo J Quintana,
Alice C Silva,
Alois P Provost,
Alysia M Salonia,
Alyssa R Favro,
Amber G Wardwell,
Amy C Jordan,
Andrew J Seaborn,
Andrew M Barlow,
Anna M Brannen,
Anne E Carpenter,
Annet R Rajan,
Anthony N Onianwa,
Ashley M Whitehurst,
Bradford L Swanson,
Bradley D Newsad,
Brandy L Couillard,
Camerson E Moore,
Carl A Huffman, III,
Carla C Tuite,
Carolyn A Pinney,
Christopher A Demitrius,
Constance Desimone,
Courtney N Long,
Daniel E Needham,
Darin S Wiegers,
Daryl A Dewoskin,
David C Sullivan,
David J Feria,
David P Vanhouten,
Dawn M Braswell,
Dean R Rugnetta,
Dien N Nguyen,
Dolores Harper,
Dorothy W Lee,
Douglas S Joslin,
Edmund F Mrak, Jr,
Eduardo L Rodriguez,
Elizabeth B Griffin,
Ellen P Madigan,
Gary J Hagan,
George T Allen, Jr,
Gerard D Difiore,
Greg W Hites,
Isaac K Carney,
James W Whitney,
Jamie S Mathews,
Janis S Gallagher,
Jason A Rossi,
Jeffrey R Alling,
John A Hamilton, III,
John A Sciacchitano,
John D White,
John J Thibodeau,
John P Mistler,
John P Shelton,
John R Carlson,
John S Hartford,
Jonah S Ufferfilge,
Jonathan B Lewis,
Jonathan G Matrisciano,
Jorge E Martinez,
Joseph T Frost,
Joyce A Kellett,
Justine M Corson,
Katarzyna Plona,
Kathleen E Mcafoose,
Kent A Conforti,
Kip J Hanks,
La Tasham Gunter,
Laurie A Haxel,
Laurie B Frazier,
LCDR Debra Emerson,
Lequita M Mayhew,
Liz M Otero,
Lorayne A Mcguinness,
Lori A Holmquist,
Lori M Newman,
Louis Christy,
Marcia M Laughrey,
Margaret E Walsh,
Mark K Tseng,
Marlene L Davis,
Martin J Guardia,
Mary E Baker Brown,
Mary Jeanet Mcgarry,
Maryam Tabatabaie,
Maura Rooney,
Michael J Leal,
Michael P Sweeney,
Michelle M Noe Varga,
Monique C Lo,
Mutahar S Shamsi,
Nabil Nakhoul,
Nadia R Barreda,
Nicholas J Scire,
Nisha C Patel,
Osama A Khatib,
Pamela L Ogonowski,
Paraluman S Leonin,
Patricia A Clark,
Paul P Geraci,
Paula M Laplant,
Perry H Gambrell,
Rebecca A Coleman,
Richard F Hapke,
Robert J Martin,
Robert O'brian,
Rosa M Santiago,
Rupa Pradhan,
Saleem A Akhtar,
Sean R Marcsisin,
Seth A Mailhot,
Sherry M Nisson,
Stacey S Degarmo,
Stephen C Smith,
Steven M Ferrara,
Susanne M Richardson, MS RAC,
Sylvia A Craven,
Tamara M Kays,
Tamara S Rosbury,
Tania K Mercado,
Tanya R Syffrard,
Tarsha T Mcclendon,
Thomas Cote,
Thomas H Jenkins,
Thomas O Morgan,
Thomas Siebertz,
Timothy M Glod,
Troy R Petrillo,
Victoria Rosales,
Victoria Taylor
Garry H Stewart's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2003 | EIR | Rhode Island Blood Center, A Division of New York Blood Center, Inc. - EIR, 2003-06-19 |
December, 2000 | FDA 483 Response | Coral Blood Services Inc. - Form 483R, 2001-05-05 |
May, 2000 | EIR | ARC/National Testing Lab - EIR, 2000-05-26 |
April, 2000 | EIR | Daniel A. Nadeau, MD, Diabetes Endocrine & Nutrition Center - EIR, 2000-04-19 |
July, 2002 | FDA 483 | Littleton Regional Hospital, BB - Form 483, 2002-07-03 |
December, 2000 | FDA 483 | Coral Blood Services Inc. - Form 483, 2000-12-29 |
November, 2000 | FDA 483 | Coral Blood Services, Inc. - Form 483, 2000-11-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more